Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010
Antimicrobial-resistance in streptococcus pneumoniae isolates causing pneumonia in Spanish people over 50 years Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Quinolones consume and streptococcus pneumoniae antibiotic resistance Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Prevalence of penicillin-resistant streptococcus pneumoniae in two community hospitals in Japan Source: Eur Respir J 2007; 30: Suppl. 51, 409s Year: 2007
Penicillin resistance rates for streptococcus pneumoniae strains isolated from lower respiratory tract infections Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002
Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
S. pneumoniae community-acquired pneumonia (SP-CAP): relationship between mortality and antibiotic susceptibility and risk factors for drug resistanceSource: Eur Respir J 2001; 18: Suppl. 33, 503s Year: 2001
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002
Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001
Antibiotic susceptibility testing on streptococcus pneumoniae strains obtained from respiratory tract specimens Source: Eur Respir J 2001; 18: Suppl. 33, 139s Year: 2001
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002
Emergence of penicillin resistant Streptococcus pneumoniae in Pakistan Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005
Streptococcus pneumoniae resistance pattern and its clinical implicationsSource: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007
Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006
The impact of antibiotic resistance in the management of lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=131 Year: 2004